Cargando…

Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis

BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolen, Erin, Stern, Karen, Humphreys, Mitchell, Brady, Alexandra, Leavitt, Todd, Zhang, Nan, Keddis, Mira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862062/
https://www.ncbi.nlm.nih.gov/pubmed/35211306
http://dx.doi.org/10.1093/ckj/sfab208
_version_ 1784654990061600768
author Bolen, Erin
Stern, Karen
Humphreys, Mitchell
Brady, Alexandra
Leavitt, Todd
Zhang, Nan
Keddis, Mira
author_facet Bolen, Erin
Stern, Karen
Humphreys, Mitchell
Brady, Alexandra
Leavitt, Todd
Zhang, Nan
Keddis, Mira
author_sort Bolen, Erin
collection PubMed
description BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and the presence of stones after follow-up. METHODS: We retrospectively evaluated kidney transplant recipients who were diagnosed with transplant nephrolithiasis between 2009 and 2019. Computed tomography and ultrasound imaging were used to confirm stone presence. RESULTS: The incidence of allograft kidney stone formation was 0.86% of 6548 kidney transplant recipients. Of the 56 cases identified, 17 (30%) had a pretransplant history of nephrolithiasis. Only four (7%) patients received a known kidney stone at the time of allograft implantation. Of the 56 cases, 34 had a 24-h supersaturation study. The urine supersaturation study showed 32 patients (94%) had a urine citrate of <450 mg excreted in 24 h (median 124.5 mg/24 h, reference range >500 mg/24 h), along with 22 patients (61%) having a urine oxalate excretion of ≥30 mg in 24 h (median 34.4 mg/24 h, reference range <30 mg/24 h). Calcium oxalate composition was most common (91% with >1 supersaturation for calcium oxalate crystals), with normal median urine calcium levels (median urine calcium 103.5 mg/24 h, reference range <200 mg/24 h). After a 4-year follow-up, 50% (n = 28) required surgical intervention and 43 (77%) patients continued to have evidence of transplant nephrolithiasis on imaging. CONCLUSIONS: This is the largest study of transplant nephrolithiasis confirming that hypocitraturia and hyperoxaluria were the most significant urine metabolic risk factors associated with allograft nephrolithiasis and that hyperoxaluria was the most prevalent driver for calcium oxalate stone composition. Our study is first to show low stone-free rates at the last follow-up and a significant proportion requiring surgical intervention.
format Online
Article
Text
id pubmed-8862062
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88620622022-02-23 Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis Bolen, Erin Stern, Karen Humphreys, Mitchell Brady, Alexandra Leavitt, Todd Zhang, Nan Keddis, Mira Clin Kidney J Original Article BACKGROUND: Nephrolithiasis in allograft kidneys is rare, but this diagnosis may lead to allograft complications and patient morbidity. Previous studies that have evaluated nephrolithiasis posttransplant have focused on surgical stone management, with limited data on urine metabolic risk factors and the presence of stones after follow-up. METHODS: We retrospectively evaluated kidney transplant recipients who were diagnosed with transplant nephrolithiasis between 2009 and 2019. Computed tomography and ultrasound imaging were used to confirm stone presence. RESULTS: The incidence of allograft kidney stone formation was 0.86% of 6548 kidney transplant recipients. Of the 56 cases identified, 17 (30%) had a pretransplant history of nephrolithiasis. Only four (7%) patients received a known kidney stone at the time of allograft implantation. Of the 56 cases, 34 had a 24-h supersaturation study. The urine supersaturation study showed 32 patients (94%) had a urine citrate of <450 mg excreted in 24 h (median 124.5 mg/24 h, reference range >500 mg/24 h), along with 22 patients (61%) having a urine oxalate excretion of ≥30 mg in 24 h (median 34.4 mg/24 h, reference range <30 mg/24 h). Calcium oxalate composition was most common (91% with >1 supersaturation for calcium oxalate crystals), with normal median urine calcium levels (median urine calcium 103.5 mg/24 h, reference range <200 mg/24 h). After a 4-year follow-up, 50% (n = 28) required surgical intervention and 43 (77%) patients continued to have evidence of transplant nephrolithiasis on imaging. CONCLUSIONS: This is the largest study of transplant nephrolithiasis confirming that hypocitraturia and hyperoxaluria were the most significant urine metabolic risk factors associated with allograft nephrolithiasis and that hyperoxaluria was the most prevalent driver for calcium oxalate stone composition. Our study is first to show low stone-free rates at the last follow-up and a significant proportion requiring surgical intervention. Oxford University Press 2021-10-20 /pmc/articles/PMC8862062/ /pubmed/35211306 http://dx.doi.org/10.1093/ckj/sfab208 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Bolen, Erin
Stern, Karen
Humphreys, Mitchell
Brady, Alexandra
Leavitt, Todd
Zhang, Nan
Keddis, Mira
Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title_full Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title_fullStr Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title_full_unstemmed Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title_short Urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
title_sort urine metabolic risk factors and outcomes of patients with kidney transplant nephrolithiasis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862062/
https://www.ncbi.nlm.nih.gov/pubmed/35211306
http://dx.doi.org/10.1093/ckj/sfab208
work_keys_str_mv AT bolenerin urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT sternkaren urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT humphreysmitchell urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT bradyalexandra urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT leavitttodd urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT zhangnan urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis
AT keddismira urinemetabolicriskfactorsandoutcomesofpatientswithkidneytransplantnephrolithiasis